IL1RL2 and achondroplasia: GPP and ACH may occur due to overexpression of IL‐36 and the loss-of-function mutation in the IL-36 receptor antagonist (IL-36RA), which leads to increased levels of pro-inflammatory cytokines and activation of IL-36 receptors in skin cells (8–10).